✦ LIBER ✦

An update on antiretroviral therapy and the role of protease inhibitors

✍ Scribed by Mariane McLaughlin

Book ID: 114183708
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 905 KB
Volume: 20
Category: Article
ISSN: 0196-4399
DOI: 10.1016/s0196-4399(00)88641-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An Update and Review of Antiretroviral T

An Update and Review of Antiretroviral Therapy

✍ Frank J. Piacenti 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB

Antiretroviral Therapy and Efficacy Afte

Antiretroviral Therapy and Efficacy After Virologic Failure on First-line Boosted Protease Inhibitor Regimens

✍ Zheng, Y.; Hughes, M. D.; Lockman, S.; Benson, C. A.; Hosseinipour, M. C.; Campb 📂 Article 📅 2014 🏛 University of Chicago Press 🌐 English ⚖ 292 KB

Broadening the perspective when assessin

Broadening the perspective when assessing evidence on boosted protease inhibitor-based regimens for initial antiretroviral therapy

✍ John Hornberger; Kit Simpson; Ashwini Shewade; Birgitta Dietz; Robert Baran; Tho 📂 Article 📅 2010 🏛 Springer Healthcare Communications 🌐 English ⚖ 216 KB

Stroke and atherothrombosis: an update o

Stroke and atherothrombosis: an update on the role of antiplatelet therapy

✍ Andrei V. Alexandrov; Peter Alagona 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB

Cutaneous toxicities of antiretroviral t

Cutaneous toxicities of antiretroviral therapy for HIV: Part I. Lipodystrophy syndrome, nucleoside reverse transcriptase inhibitors, and protease inhibitors

✍ Camille E. Introcaso; Janet M. Hines; Carrie L. Kovarik 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 660 KB

Cutaneous toxicities of antiretroviral t

Cutaneous toxicities of antiretroviral therapy for HIV: Part I. Lipodystrophy syndrome, nucleoside reverse transcriptase inhibitors, and protease inhibitors

✍ Camille E. Introcaso; Janet M. Hines; Carrie L. Kovarik 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 660 KB

Antiretroviral medications for the treatment of HIV are common drugs with diverse and frequent skin manifestations. Multiple new cutaneous effects have been recognized in the past decade. Dermatologists play an important role in accurately diagnosing and managing the cutaneous toxicities of these me